The historical rank and industry rank for ASKA Pharmaceutical Holdings Co's Pretax Margin % or its related term are showing as below:
TSE:4886'
s Pretax Margin % Range Over the Past 10 Years
Min: 8.86 Med: 9.83 Max: 15.69
Current: 9.83
TSE:4886's Pretax Margin % is ranked better than 58.18% of 954
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs TSE:4886: 9.83
ASKA Pharmaceutical Holdings Co (TSE:4886) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
ASKA Pharmaceutical Holdings Co Pretax Margin % Related Terms
ASKA Pharmaceutical Holdings Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASKA Pharmaceutical Holdings Co Pretax Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, ASKA Pharmaceutical Holdings Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASKA Pharmaceutical Holdings Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ASKA Pharmaceutical Holdings Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where ASKA Pharmaceutical Holdings Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASKA Pharmaceutical Holdings Co (TSE:4886) has a Pretax Margin % of 12.26% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on ASKA Pharmaceutical Holdings Co and its competitors. This is 25% above median its historical median of 9.83. Over the past decade, ASKA Pharmaceutical Holdings Co's Pretax Margin % has ranged from 8.86 to 15.69. According to the industry distribution chart, ASKA Pharmaceutical Holdings Co ranks #399 out of 954 companies in the Drug Manufacturers industry, placing it in the top 41.8%.
Is ASKA Pharmaceutical Holdings Co's Pretax Margin % too high?
ASKA Pharmaceutical Holdings Co's current Pretax Margin % of 12.26% is 25% above median its 10-year median of 9.83. Over the past 10 years, this metric has ranged from a low of 8.86 to a high of 15.69. The Drug Manufacturers industry median Pretax Margin % is 7.30. ASKA Pharmaceutical Holdings Co's value of 12.26% is 68.1% above this industry median. Based on the distribution chart, ASKA Pharmaceutical Holdings Co ranks #399 out of 954 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, ASKA Pharmaceutical Holdings Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ASKA Pharmaceutical Holdings Co's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, ASKA Pharmaceutical Holdings Co ranks #399 out of 954 companies for Pretax Margin %. This puts ASKA Pharmaceutical Holdings Co in the upper half of its industry. The industry median Pretax Margin % is 7.30. ASKA Pharmaceutical Holdings Co's value of 12.26% is 68.1% above this benchmark. Historically, ASKA Pharmaceutical Holdings Co's own Pretax Margin % has ranged from 8.86 to 15.69 over the past decade. While the company's 10-year median is 9.83 vs. the industry median of 7.30, ASKA Pharmaceutical Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ASKA Pharmaceutical Holdings Co's current Pretax Margin % of 12.26% is 68.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on ASKA Pharmaceutical Holdings Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ASKA Pharmaceutical Holdings Co's current Pretax Margin % is 12.26%, which is 25% above median its own 10-year median of 9.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASKA Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co (TSE:4886) is currently considered Fairly Valued. The stock's GF Value™ is 円2,399.40, compared to a current price of 円2,391.00 — trading 0.4% below its estimated fair value. The current Pretax Margin % is 12.26%, which is 25% above median its 10-year median of 9.83 and 68.1% above the Drug Manufacturers industry median of 7.30. ASKA Pharmaceutical Holdings Co's overall GF Score™ is 62/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For ASKA Pharmaceutical Holdings Co (TSE:4886), the current Pretax Margin % is 12.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ASKA Pharmaceutical Holdings Co (TSE:4886) Overvalued in 2026?
Based on GuruFocus' analysis, ASKA Pharmaceutical Holdings Co stock appears to be undervalued.
The current stock price of 円2,391.00 is trading 0.4% below its estimated GF Value™ of 円2,399.40.
GuruFocus considers ASKA Pharmaceutical Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4886:
Pretax Margin %: 12.26% (25% above median its 10-year median of 9.83)
GF Value™: 円2,399.40 vs. price of 円2,391.00 (0.4% below fair value)
Industry Position: 68.1% above the Drug Manufacturers median (#399 of 954)
No single metric tells the full story. See the TSE:4886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ASKA Pharmaceutical Holdings Co Business Description
ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and other related operations.
62GF Score
Get the complete analysis for TSE:4886
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4886 has been successfully added to your 
